Biocryst Pharmaceuticals (BCRX) Change in Cash: 2009-2024
Historic Change in Cash for Biocryst Pharmaceuticals (BCRX) over the last 16 years, with Dec 2024 value amounting to -$6.1 million.
- Biocryst Pharmaceuticals' Change in Cash rose 73.39% to -$17.7 million in Q4 2015 from the same period last year, while for Dec 2015 it was -$25.6 million, marking a year-over-year decrease of 176.82%. This contributed to the annual value of -$6.1 million for FY2024, which is 96.84% up from last year.
- According to the latest figures from FY2024, Biocryst Pharmaceuticals' Change in Cash is -$6.1 million, which was up 96.84% from -$193.8 million recorded in FY2023.
- Biocryst Pharmaceuticals' 5-year Change in Cash high stood at $233.4 million for FY2021, and its period low was -$201.5 million during FY2022.
- For the 3-year period, Biocryst Pharmaceuticals' Change in Cash averaged around -$133.8 million, with its median value being -$193.8 million (2023).
- Per our database at Business Quant, Biocryst Pharmaceuticals' Change in Cash crashed by 186.34% in 2022 and then spiked by 96.84% in 2024.
- Biocryst Pharmaceuticals' Change in Cash (Yearly) stood at $158.6 million in 2020, then soared by 47.13% to $233.4 million in 2021, then tumbled by 186.34% to -$201.5 million in 2022, then grew by 3.82% to -$193.8 million in 2023, then surged by 96.84% to -$6.1 million in 2024.